Azam Bolhassani Selected Research

Azam Bolhassani Research Topics

Disease

55	Neoplasms (Cancer) 03/2024 - 10/2008
27	Infections 05/2024 - 01/2013
11	Virus Diseases (Viral Diseases) 12/2023 - 06/2008
9	Papillomavirus Infections 01/2022 - 10/2009
7	Communicable Diseases (Infectious Diseases) 11/2019 - 10/2008
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2019 - 06/2008
5	HIV Infections (HIV Infection) 01/2022 - 01/2014
4	Hemophilia A (Haemophilia) 01/2020 - 12/2018
3	COVID-19 05/2023 - 01/2020
3	Noncommunicable Diseases 05/2023 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2023 - 07/2021
2	Visceral Leishmaniasis (Kala Azar) 04/2016 - 01/2013
1	Lung Neoplasms (Lung Cancer) 03/2024
1	Disease Progression 05/2023
1	Herpes Simplex 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/2020
1	Transfusion Reaction 01/2020
1	Hepatitis 01/2020
1	Thalassemia 12/2019
1	Hemorrhage 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Eye Diseases (Eye Disease) 01/2017
1	Inflammation (Inflammations) 01/2017

Drug/Important Bio-Agent (IBA)

59	VaccinesIBA 02/2024 - 06/2008
32	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2008
17	Peptides (Polypeptides)IBA 09/2023 - 10/2009
16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2008
11	AntigensIBA 05/2023 - 10/2009
6	Therapeutic UsesIBA 11/2021 - 02/2015
5	Immunoglobulin G (IgG)IBA 01/2021 - 11/2012
5	DNA VaccinesIBA 10/2020 - 07/2009
4	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2024 - 10/2009
4	crocinIBA 01/2021 - 01/2014
4	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 12/2018
4	Carotenoids (Carotene)IBA 01/2017 - 01/2014
3	HSP27 Heat-Shock ProteinsIBA 01/2024 - 02/2019
3	Recombinant ProteinsIBA 01/2024 - 11/2009
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
3	CytokinesIBA 01/2022 - 01/2014
3	EpitopesIBA 08/2021 - 01/2018
3	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 10/2018
3	Viral ProteinsIBA 11/2019 - 06/2008
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2019 - 01/2019
3	RetinoidsIBA 01/2017 - 01/2014
2	Green Fluorescent ProteinsIBA 01/2024 - 01/2018
2	Granzymes (Granzyme)IBA 01/2024 - 09/2018
2	Nucleic AcidsIBA 09/2023 - 12/2011
2	Cell-Penetrating PeptidesIBA 09/2023 - 12/2011
2	CurcuminIBA 11/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 02/2019
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 03/2020 - 01/2020
2	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 01/2016
2	InterferonsIBA 01/2020 - 06/2015
2	HMGB1 Protein (HMG1)IBA 02/2019 - 01/2017
2	Small Heat-Shock ProteinsIBA 01/2019 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2009
2	Anti-HIV Agents (AIDS Drugs)IBA 01/2019 - 01/2018
2	picrocrocinIBA 01/2018 - 02/2015
2	Capsid Proteins (Capsid Protein)IBA 09/2015 - 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2024
1	EnzymesIBA 12/2023
1	Drug CarriersIBA 09/2023
1	Immunologic Factors (Immunomodulators)IBA 05/2023
1	mRNA VaccinesIBA 05/2023
1	LipidsIBA 05/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Antimicrobial PeptidesIBA 01/2023
1	CathelicidinsIBA 01/2023
1	LipofectamineIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Immunodominant EpitopesIBA 08/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	ProteomeIBA 01/2021
1	Human Immunodeficiency Virus ProteinsIBA 01/2021
1	Protein Subunit VaccinesIBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	NucleotidesIBA 12/2019
1	Molecular Chaperones (Chaperone, Molecular)IBA 11/2019
1	Genetic Markers (Genetic Marker)IBA 12/2018
1	Neutralizing AntibodiesIBA 12/2018
1	Interleukin-2 (IL2)IBA 12/2018
1	NanovaccinesIBA 09/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2017
1	Monatide (IMS 3015)IBA 01/2017
1	CateninsIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Synthetic Vaccines (Recombinant Vaccines)IBA 04/2016

Therapy/Procedure

15	Therapeutics 03/2024 - 01/2011
7	Immunotherapy 03/2024 - 10/2009
2	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 01/2021
2	Chemoprevention 01/2017 - 01/2015
1	Oncolytic Virotherapy 03/2024
1	Art Therapy 05/2023
1	Blood Transfusion (Blood Transfusions) 01/2020
1	Aftercare (After-Treatment) 09/2018
1	Phytotherapy (Herbal Therapy) 01/2018